| Quarterly Financials | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 80 | 104 | 80 | 100 | 108 | 126 | 134 | 159 | 178 | 193 |
| Expenses | 64 | 80 | 59 | 77 | 77 | 95 | 104 | 112 | 121 | 128 |
| EBITDA | 16 | 24 | 21 | 23 | 31 | 31 | 30 | 47 | 58 | 65 |
| Operating Profit % | 19 % | 22 % | 26 % | 21 % | 25 % | 17 % | 20 % | 27 % | 29 % | 27 % |
| Depreciation | 3 | 4 | 4 | 4 | 4 | 5 | 6 | 8 | 8 | 9 |
| Interest | 3 | 3 | 5 | 5 | 6 | 5 | 5 | 6 | 5 | 9 |
| Profit Before Tax | 10 | 18 | 14 | 16 | 21 | 21 | 27 | 41 | 45 | 47 |
| Tax | 3 | 3 | 3 | 3 | 4 | 3 | 5 | 11 | 11 | 11 |
| Net Profit | 7 | 14 | 11 | 13 | 16 | 18 | 21 | 30 | 34 | 37 |
| EPS in ₹ | 4.01 | 8.03 | 3.39 | 3.92 | 5.04 | 3.81 | 4.60 | 6.54 | 7.29 | 7.96 |
Senores Pharmaceuticals
Senores Pharmaceuticals
1,054.90
+21.40
(2.07%)
Market Cap
4,858.19 Cr
PE Ratio
39.28
Volume
3,05,163.00
Day High - Low
1,061.00 - 1,015.10
52W High-Low
1,194.40 - 510.25
Key Fundamentals
Market Cap
4,858.19 Cr
EPS
26.39
PE Ratio
39.28
PB Ratio
5.11
Book Value
202.72
EBITDA
168.32
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
7.18
Debt to Equity
0.58
Analyst Rating and Forecast
- By Refinitiv from4 analysts
Actual
Company News
View All News
Senores Pharma to meet investors
May 20, 2026
May 20, 2026Senores Pharmaceuticals Limited will hold an investor conference in Mumbai on May 25, 2026. The meeting is hosted by Ambit Capital.
Senores Pharmaceuticals targets 30-40% revenue growth and ~60% profit growth in FY27, following a strong FY26 with PAT surging 108% to Rs 122 crores.
Senores Pharma Board Meet Set for May 14, 2026May 08, 2026
May 08, 2026Senores Pharmaceuticals has scheduled a Board of Directors meeting on May 14, 2026, to consider audited financial results for Q4 and FY26.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,789.90 | #1 4,29,456.97 | 37.31 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 44.62 | |
6,565.50 | 1,74,293.40 | 67.49 | 10,560.00 | 8.73 | 2,520 | 13.44 | 44.07 | |
4,380.00 | 1,48,239.10 | 68.30 | 13,753.00 | 19.18 | 2,028 | -26.91 | 46.97 | |
1,373.10 | 1,10,916.36 | 28.84 | 27,711.70 | -2.46 | 3,783 | -55.32 | 53.76 | |
1,076.00 | 1,08,270.78 | 21.16 | 26,719.70 | 13.65 | 5,242 | 7.82 | 69.53 | |
1,262.90 | 1,05,407.07 | 25.59 | 33,593.30 | -0.44 | 3,998 | -86.05 | 43.69 | |
2,260.00 | 1,03,291.77 | #1 19.21 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 42.84 | |
2,376.00 | 98,082.49 | 48.97 | 14,277.60 | 12.03 | 1,750 | 31.75 | 42.75 | |
1,435.00 | 83,345.03 | 23.70 | 33,384.70 | 3.21 | 3,376 | 1.99 | 46.16 | |
1,392.30 | 75,164.23 | 83.88 | 6,812.90 | #1 21.03 | 884 | 21.18 | 74.67 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
51.53 %
Net Income Growth
138.70 %
Cash Flow Change
-78.68 %
ROE
-49.15 %
ROCE
1.63 %
EBITDA Margin (Avg.)
-5.13 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 59 | 131 | 622 | 1,227 | 1,604 |
| Fixed Assets | 7 | 27 | 235 | 301 | 726 |
| Current Assets | 27 | 51 | 251 | 722 | 812 |
| Capital Work in Progress | 8 | 35 | 97 | 173 | 18 |
| Investments | 15 | 17 | 0 | 0 | 89 |
| Other Assets | 29 | 53 | 289 | 754 | 0 |
| Total Equity & Liabilities | 59 | 131 | 622 | 1,227 | 1,604 |
| Current Liabilities | 10 | 52 | 248 | 241 | 424 |
| Non Current Liabilities | 13 | 34 | 143 | 174 | 215 |
| Total Equity | 37 | 46 | 232 | 812 | 934 |
| Reserve & Surplus | 28 | 36 | 174 | 740 | 888 |
| Share Capital | 9 | 10 | 31 | 46 | 46 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 2 | -3 | 8 | 98 |
| Investing Activities | -24 | -48 | -54 | -430 |
| Operating Activities | -10 | -1 | -26 | -46 |
| Financing Activities | 37 | 46 | 87 | 573 |
Share Holding
| % Holding | Jul 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 66.66 % | 45.76 % | 45.76 % | 45.77 % | 45.78 % | 45.80 % | 45.80 % | 45.82 % |
| FIIs | 0.00 % | 5.51 % | 4.25 % | 4.17 % | 3.67 % | 4.28 % | 3.35 % | 3.64 % |
| DIIs | 0.00 % | 18.61 % | 11.78 % | 9.65 % | 9.51 % | 8.61 % | 9.31 % | 9.61 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 27.88 % | 28.71 % | 31.43 % | 31.44 % | 31.09 % | 31.94 % | 31.64 % |
| Others | 33.34 % | 2.23 % | 9.49 % | 8.97 % | 9.60 % | 10.22 % | 9.59 % | 9.30 % |
| No of Share Holders | 177 | 43,707 | 43,707 | 37,653 | 36,389 | 34,917 | 34,401 | 34,126 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 23 Jan 2025 |  Quarterly Result Announcement | NA | 23 Jan 2025 | 530.80 | 498.50 |
| 15 May 2025 | Quarterly Result Announcement | NA | 15 May 2025 | 483.75 | 541.05 |
| 23 Jul 2025 | Quarterly Result Announcement | NA | 23 Jul 2025 | 617.55 | 616.35 |
| 18 Sept 2025 |  Annual General Meeting | NA | 18 Sept 2025 | 717.85 | 689.25 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 783.35 | 766.75 |
| 20 Jan 2026 | Quarterly Result Announcement | NA | 20 Jan 2026 | 812.35 | 806.55 |
| 31 Jan 2026 |  Extraordinary General Meeting | NA | 31 Jan 2026 | 845.15 | 787.35 |
| 14 May 2026 | Quarterly Result Announcement | NA | 14 May 2026 | 932.45 | 977.10 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
May 22, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2026
May 21, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 20, 2026
May 20, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 15, 2026
May 15, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 14, 2026
May 14, 2026Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue Of Convertible Equity Warrants For The Quarter Ended On March 31 2026
May 14, 2026
May 14, 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)May 14, 2026
May 14, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 14, 2026
May 14, 2026Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On March 31 2026May 14, 2026
May 14, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 14, 2026
May 14, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 14, 2026
May 14, 2026Financial Results For Quarter And Financial Year Ended March 31 2026May 14, 2026
May 14, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On May 14 2026May 14, 2026
May 14, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 08, 2026
May 08, 2026Board Meeting Intimation for Considering And Approving The Audited Consolidated And Standalone Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 And To Transact Other Business MattersMay 08, 2026
May 08, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2026
Apr 29, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Apr 06, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 03, 2026
Apr 03, 2026Announcement under Regulation 30 (LODR)-AcquisitionApr 03, 2026
Apr 03, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 01, 2026
Apr 01, 2026Announcement under Regulation 30 (LODR)-AllotmentMar 28, 2026
Mar 28, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On March 28 2026Mar 28, 2026
Mar 28, 2026Closure of Trading WindowMar 27, 2026
Mar 27, 2026Intimation Regarding Changes In The Senior Management Personnel (SMP) Of The CompanyMar 17, 2026
Mar 17, 2026Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Mar 12, 2026
Mar 12, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 09, 2026
Mar 09, 2026Announcement Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 03, 2026
Mar 03, 2026Announcement Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 03, 2026
Mar 03, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 02, 2026
Mar 02, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 02, 2026
Mar 02, 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Feb 17, 2026
Feb 17, 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Feb 17, 2026
Feb 17, 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Feb 17, 2026
Feb 17, 2026Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Feb 17, 2026
Feb 17, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 13, 2026
Feb 13, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 04, 2026
Feb 04, 2026Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 31, 2026
Jan 31, 2026Shareholder Meeting / Postal Ballot-Outcome of EGMJan 31, 2026
Jan 31, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 27, 2026
Jan 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 21, 2026
Jan 21, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 20, 2026
Jan 20, 2026Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On December 31 2025Jan 20, 2026
Jan 20, 2026Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On December 31 2025Jan 20, 2026
Jan 20, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportJan 20, 2026
Jan 20, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 20, 2026
Jan 20, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 20, 2026
Jan 20, 2026Corrigendum To The Media Release Submitted With The Outcome Of The Board Meeting Dated January 20 2026Jan 20, 2026
Jan 20, 2026Results For Quarter And Nine Months Ended December 31 2025Jan 20, 2026
Jan 20, 2026Board Meeting Outcome for Outcome Of Board MeetingJan 20, 2026
Jan 20, 2026Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bajaj Finserv Small Cap Fund Direct-Growth | 0.47% | 100000 | 0.47% | 0.47% | |
Bajaj Finserv Healthcare Fund Direct-Growth | 0.84% | 0 | 0.00% | 0.84% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.16% | 0 | 0.00% | 0.02% | |
 Bank of India Mid & Small Cap Equity & Debt Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
Bank of India Multi Cap Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 HSBC Multi Cap Fund Direct-Growth | 0.41% | 0 | 0.00% | 0.12% | |
HSBC Small Cap Fund Direct-Growth | 0.26% | 0 | 0.00% | 0.04% | |
HSBC Value Fund Direct-Growth | 0.28% | 0 | 0.00% | 0.01% | |
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth | 0.21% | 0 | 0.00% | -0.56% | |
 Mahindra Manulife Balanced Advantage Fund Direct-Growth | 1.08% | 0 | 0.00% | 0.10% | |
Mahindra Manulife Large & Mid Cap Fund Direct-Growth | 1.81% | 0 | 0.00% | 0.14% | |
 WhiteOak Capital Pharma and Healthcare Fund Direct-Growth | 0.85% | 0 | 0.00% | 0.85% |
Technical Indicators
RSI(14)
Neutral 52.54
ATR(14)
Volatile 55.47
STOCH(9,6)
Neutral 54.14
STOCH RSI(14)
Oversold 9.62
MACD(12,26)
Bearish -6.83
ADX(14)
Strong Trend 43.50
UO(9)
Bearish 44.23
ROC(12)
Uptrend And Accelerating 8.26
WillR(14)
Neutral -55.91
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
